-
The Epidemiology Burden and Management of Chronic Hand Eczema in Adolescents: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Using Expert Consensus to Expand Access in Rare Disease Populations: Generating Evidence for Patients With Permanently Ventilated Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM -
Building the Bridge to Access: Leveraging RWE From Early Access Schemes to Reimbursement in Gene and Cell Therapies
Sep 9, 2025, 16:22 PM -
Predictors of Effectiveness of Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs in the Treatment of Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Comparative Clinical Effectiveness in Skin Cancer: Lessons From HTA Decision Making in EU4, UK, and Australia
Sep 9, 2025, 16:22 PM -
Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events
Sep 9, 2025, 16:22 PM -
Environmental Impact of Intravenous vs. Oral Chemotherapy in France: A 1000-Patient Model-Based Assessment
Sep 9, 2025, 16:22 PM -
Cost per Responder Analysis of Bimekizumab, a Monoclonal IgG1 Antibody Which Selectively Inhibits Il17f in Addition to Il17a Against Il17a Inhibitors in the Treatment of Axial Spondyloarthritis in Finland
Sep 9, 2025, 16:22 PM -
The Value of Medical Spending in China, 1991-2019
Sep 9, 2025, 16:22 PM -
Evaluating Treatment Benefit and Tolerability Based on Responder and Time-to-Event Analysis of Patient-Reported Outcomes in Cancer Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Disease Burden of MASH/MASLD Among People With Obesity in China, Japan, and EU5
Sep 9, 2025, 16:22 PM -
Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States
Sep 9, 2025, 16:22 PM -
The Real-World Impact of Step Therapy and Prior Authorization on Patients, Clinicians, and US Health Plans: Lessons to Be Learned in Europe
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Projected Public Health Benefits of Nirsevimab for RSV Prevention in Infants in Greece
Sep 9, 2025, 16:22 PM -
Analysis of a Cancer Profile of 10 European States
Sep 9, 2025, 16:22 PM -
NICE Decisions in the Southwest Quadrant
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM -
From Data to Decisions: Enhancing Real-World Data Quality: A Survey of Health Data Producers in France
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions
Sep 9, 2025, 16:22 PM
